Anmeldung erfolgt in Kürze...
Details werden geladen...
Sanofi: Sanofi's Tzield approved in the US as the first disease-modifying therapy for patients recently diagnosed with stage 3 type 1 diabetes
Sanofi's Tzield approved in the US as the first disease-modifying therapy for patients recently diagnosed with stage 3 type 1 diabetes Accelerated approval in children aged eight to 17 years old recently
Ähnliche Seiten
Press Release: Sanofi’s Tzield approved in the US as the first disease-modifying therapy for patients recently diagnosed with stage 3 type 1 diabetes | The Manila Times
https://www.manilatimes.net/2026/06/13/tmt-newswire/globenewswire/press-release-sanofis-tzield-approved-in-the-us-as-the-first-disease-modifying-therapy-for-patients-recently-diagnosed-with-stage-3-type-1-diabetes/2364747
FDA Grants Accelerated Approval To Sanofi's Tzield For Children With Stage 3 Type 1 Diabetes
https://www.finanznachrichten.de/nachrichten-2026-06/68758318-fda-grants-accelerated-approval-to-sanofi-s-tzield-for-children-with-stage-3-type-1-diabetes-020.htm
FDA Grants Accelerated Approval To Sanofi's Tzield For Children With Stage 3 Type 1 Diabetes | 13.06.26 | finanzen.ch
https://www.finanzen.ch/nachrichten/aktien/fda-grants-accelerated-approval-to-sanofis-tzield-for-children-with-stage-3-type-1-diabetes-1036247436
FDA Grants Accelerated Approval To Sanofi's Tzield For Children With Stage 3 Type 1 Diabetes | 13.06.26 | finanzen.at
https://www.finanzen.at/nachrichten/aktien/fda-grants-accelerated-approval-to-sanofis-tzield-for-children-with-stage-3-type-1-diabetes-1036247436
FDA approves Sanofi diabetes drug for children with stage 3 diabetes | STAT
https://www.statnews.com/2026/06/13/teplizumab-tzield-sanofi-fda-approval-children-stage-3-diabetes/